跳至主要内容
临床试验/CTRI/2022/02/040396
CTRI/2022/02/040396已完成未知

A RANDOMISED CONTROLLED TRIAL COMPARING VITAMIN K STATUS INLESS THAN 32WEEKS AND OR LESS THAN 1500GMS AFTER 3 PROPHYLACTIC DOSAGE REGIMENS (0.3VS 0.5 MG VS 1MG IM) AT BIRTH

il0 个研究点目标入组 75 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Preterm neonates less than 32 weeks of gestation and/or less than 1500 g born during the study period

排除标准

  • Outborn neonates who already received vitamin K, those with antenatally diagnosed major congenital malformations and intracranial hemorrhage, neonates whose mothers had thrombophilia or platelet disorders, and who received drug treatment with known vitamin K antagonists.

研究者

发起方
il

相似试验